Literature DB >> 26740388

Muenke syndrome: An international multicenter natural history study.

Paul Kruszka1, Yonit A Addissie1, Colin M P Yarnell1, Donald W Hadley1, Maria J Guillen Sacoto1, Petra Platte2, Yvonne Paelecke2, Hartmut Collmann3, Nicole Snow4,5, Tilmann Schweitzer3, Simeon A Boyadjiev6, Christos Aravidis7, Samantha E Hall8, John B Mulliken8, Tony Roscioli3,4, Maximilian Muenke1.   

Abstract

Muenke syndrome is an autosomal dominant disorder characterized by coronal suture craniosynostosis, hearing loss, developmental delay, carpal, and calcaneal fusions, and behavioral differences. Reduced penetrance and variable expressivity contribute to the wide spectrum of clinical findings. Muenke syndrome constitutes the most common syndromic form of craniosynostosis, with an incidence of 1 in 30,000 births and is defined by the presence of the p.Pro250Arg mutation in FGFR3. Participants were recruited from international craniofacial surgery and genetic clinics. Affected individuals, parents, and their siblings, if available, were enrolled in the study if they had a p.Pro250Arg mutation in FGFR3. One hundred and six patients from 71 families participated in this study. In 51 informative probands, 33 cases (64.7%) were inherited. Eighty-five percent of the participants had craniosynostosis (16 of 103 did not have craniosynostosis), with 47.5% having bilateral and 28.2% with unilateral synostosis. Females and males were similarly affected with bicoronal craniosynostosis, 50% versus 44.4% (P = 0.84), respectively. Clefting was rare (1.1%). Hearing loss was identified in 70.8%, developmental delay in 66.3%, intellectual disability in 35.6%, attention deficit/hyperactivity disorder in 23.7%, and seizures in 20.2%. In patients with complete skeletal surveys (upper and lower extremity x-rays), 75% of individuals were found to have at least a single abnormal radiographical finding in addition to skull findings. This is the largest study of the natural history of Muenke syndrome, adding valuable clinical information to the care of these individuals including behavioral and cognitive impairment data, vision changes, and hearing loss.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  FGFR3-related craniosynostosis; Muenke syndrome; craniosynostosis

Mesh:

Substances:

Year:  2016        PMID: 26740388     DOI: 10.1002/ajmg.a.37528

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

Review 1.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

2.  Muenke syndrome: Medical and surgical comorbidities and long-term management.

Authors:  Chaya N Murali; Donna M McDonald-McGinn; Tara Lynn Wenger; Carey McDougall; Bridget M Stroup; Sarah E Sheppard; Jesse Taylor; Scott P Bartlett; Elizabeth J Bhoj; Elaine H Zackai; Avni Santani
Journal:  Am J Med Genet A       Date:  2019-05-20       Impact factor: 2.802

Review 3.  Clinical genetics of craniosynostosis.

Authors:  Andrew O M Wilkie; David Johnson; Steven A Wall
Journal:  Curr Opin Pediatr       Date:  2017-12       Impact factor: 2.856

4.  A Qualitative Study to Explore the Views and Attitudes towards Prenatal Testing in Adults Who Have Muenke Syndrome and their Partners.

Authors:  Julie Phipps; Heather Skirton
Journal:  J Genet Couns       Date:  2017-03-22       Impact factor: 2.537

5.  Haploinsufficiency of ZNF462 is associated with craniofacial anomalies, corpus callosum dysgenesis, ptosis, and developmental delay.

Authors:  Karin Weiss; Kristen Wigby; Madeleine Fannemel; Lindsay B Henderson; Natalie Beck; Neeti Ghali; D D D Study; Britt-Marie Anderlid; Johanna Lundin; Ada Hamosh; Marilyn C Jones; Sondhya Ghedia; Maximilian Muenke; Paul Kruszka
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

Review 6.  Syndromic Craniosynostosis: Complexities of Clinical Care.

Authors:  Justine O'Hara; Federica Ruggiero; Louise Wilson; Greg James; Graeme Glass; Owase Jeelani; Juling Ong; Richard Bowman; Michelle Wyatt; Robert Evans; Martin Samuels; Richard Hayward; David J Dunaway
Journal:  Mol Syndromol       Date:  2019-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.